Literature DB >> 24459978

[Construction and eukaryotic expression of PVAX1-hPV58mE6E7fcGB composite gene vaccine].

He Wang1, Jiyun Yu2, Li Li1.   

Abstract

To construct and express a composite gene vaccine for human papillomavirus 58(HPV58)-associated cervical cancer, we inserted HPV58mE6E7 fusion gene into pCI-Fc-GPI eukaryotic expression vector, constructing a recombinant plasmid named pCI-sig-HPV58mE6E7-Fc-GPI. Then we further inserted fragment of sig-HPV58mE6E7Fc-GPI into the novel vaccine vector PVAX1-IRES-GM/B7, constructing PVAX1-HPV58mE6E7FcGB composite gene vaccine. PVAX1-HPV58mE6E7FcGB vaccine was successfully constructed and identified by restriction endonuclease and sequencing analysis. Eukaryotic expression of fusion antigen sig-HPV58mE6E7-Fc-GPI and molecular ad-juvant GM-CSF and B7. 1 were proved to be realized at the same time by flow cytometry and immunofluorescence. So PVAX1-HPV58mE6E7FcGB can be taken as a candidate of therapeutic vaccine for HPV58-associated tumors and their precancerous transformations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24459978

Source DB:  PubMed          Journal:  Sheng Wu Yi Xue Gong Cheng Xue Za Zhi        ISSN: 1001-5515


  1 in total

1.  Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine.

Authors:  Bing Wan; Lu Qin; Weihong Ma; He Wang
Journal:  Infect Agent Cancer       Date:  2022-02-23       Impact factor: 2.965

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.